BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6292292)

  • 1. Glycosylation and secretion of an altered immunoglobulin heavy chain in mouse myeloma MOPC 315.
    Sonenshein GE; McCormack J
    J Immunol; 1982 Dec; 129(6):2559-63. PubMed ID: 6292292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of immunoglobulin light chain restores heavy chain secretion.
    Pepe VH; Sonenshein GE; Yoshimura MI; Shulman MJ
    J Immunol; 1986 Oct; 137(7):2367-72. PubMed ID: 3093573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.
    Köhler G; Milstein C
    Eur J Immunol; 1976 Jul; 6(7):511-9. PubMed ID: 825377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis but not secretion of J chain by variant mouse myeloma cells which lose alpha-chain-synthesizing ability.
    Mosmann T; Baumal R
    J Immunol; 1975 Oct; 115(4):955-62. PubMed ID: 809509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.
    Köhler G; Howe SC; Milstein C
    Eur J Immunol; 1976 Apr; 6(4):292-5. PubMed ID: 825374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin biosynthesis by the MOPC 173 mouse myeloma tumor and a variant spleen clone.
    Baumal R; Scharff MD
    J Immunol; 1976 Jan; 116(1):65-74. PubMed ID: 812916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of immunoglobulin mRNA by a murine myeloma MOPC 315 variant cell line.
    Ponte PA; Dean M; Pepe VH; Sonenshein GE
    J Immunol; 1984 Jul; 133(1):476-81. PubMed ID: 6427346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations affecting immunoglobulin light chain secretion by myeloma cells. I. Functional analysis by cell fusion.
    Mosmann TR; Baumal R; Williamson AR
    Eur J Immunol; 1979 Jul; 9(7):511-6. PubMed ID: 115698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ig light chains are secreted predominantly as monomers.
    Dul JL; Aviel S; Melnick J; Argon Y
    J Immunol; 1996 Oct; 157(7):2969-75. PubMed ID: 8816404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of a nonsecreting myeloma mutant.
    Argon Y; Burrone OR; Milstein C
    Eur J Immunol; 1983 Apr; 13(4):301-5. PubMed ID: 6406235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mouse myeloma variant with a defect in light chain synthesis.
    Morrison SL; Scharff MD
    Eur J Immunol; 1979 Jun; 9(6):461-5. PubMed ID: 115696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mott cells: a model to study immunoglobulin secretion.
    Alanen A; Pira U; Colman A; Franklin RM
    Eur J Immunol; 1987 Nov; 17(11):1573-7. PubMed ID: 2890529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of immunoglobulin biosynthesis in the murine plasmacytoma MOPC 315.
    Siebert GR; Harris JF; Gefter ML
    J Immunol; 1978 Nov; 121(5):1808-18. PubMed ID: 101592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoid cell lines from patients with "non-secretory" agammaglobulinemia produce glycosylated heavy chains which are reduced in molecular weight.
    Schwaber J; Rosen FS
    J Mol Cell Immunol; 1984; 1(5):279-91. PubMed ID: 6443854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    Pickering JW; Gelder FB
    J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
    Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
    J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the specificities of human blood group H gene-specified alpha 1,2-L-fucosyltransferase toward sulfated/sialylated/fucosylated acceptors: evidence for an inverse relationship between alpha 1,2-L-fucosylation of Gal and alpha 1,6-L-fucosylation of asparagine-linked GlcNAc.
    Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; Matta KL
    Biochemistry; 1996 Jul; 35(27):8914-24. PubMed ID: 8688427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin glycopeptides from an IgG2b-producing mouse myeloma cell line and from variant cell lines.
    Weitzman S; Portmore J
    J Immunol; 1981 Nov; 127(5):2095-101. PubMed ID: 7299124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections.
    Senn BM; López-Macías C; Kalinke U; Lamarre A; Isibasi A; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2003 Apr; 33(4):950-61. PubMed ID: 12672061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.